CeriBell, Inc (CBLL) Income Statement
CBLL 2025 at a glance
Fiscal year ended December 31, 2025 · U.S. dollarsCBLL revenue and net income
Where CBLL's revenue goes
2025Each bar shows an amount and its share of revenue. CBLL kept −60.0% of revenue as net income.
CBLL profit margins
CBLL growth rates
to 2025| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Revenue | +36.1% | +50.9% | — | — |
| Gross profit | +37.9% | +53.9% | — | — |
| Operating income | — | — | — | — |
| Net income | — | — | — | — |
| EPS (diluted) | — | — | — | — |
1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.
CBLL quarterly EPS vs estimates
CeriBell beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 3, 2026 (estimate $-0.50).
CBLL income statement
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $89.1M | $65.4M | $45.2M | $25.9M |
| Cost of revenue | $10.8M | $8.7M | $7.1M | $4.4M |
| Gross profit | $78.3M | $56.8M | $38.2M | $21.5M |
| Research & development | $19.1M | $13.6M | $9.0M | $7.2M |
| Sales, general & admin | $117.5M | $82.9M | $59.2M | $50.3M |
| Total operating expenses | $136.7M | $96.5M | $68.2M | $57.5M |
| Operating income | −$58.4M | −$39.7M | −$30.0M | −$36.0M |
| Interest expense | $1.9M | $2.0M | $2.1M | $1.6M |
| Income before taxes | −$53.4M | −$40.5M | −$29.5M | −$37.2M |
| Income taxes | — | — | $11,000 | $2,000 |
| Net income | −$53.4M | −$40.5M | −$29.5M | −$37.2M |
| EBITDA | −$50.2M | −$37.3M | −$26.5M | −$35.1M |
| EPS (diluted) | −$1.47 | −$2.62 | −$1.26 | — |
| Gross margin | 87.9% | 86.7% | 84.4% | 82.9% |
| Operating margin | −65.6% | −60.7% | −66.4% | −139.0% |
| Net margin | −60.0% | −61.8% | −65.1% | −143.4% |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $28.1M | $26.5M | $24.8M | $22.6M | $21.2M | $20.5M | $18.5M | $17.2M | $14.9M | $14.9M | $13.1M | $11.6M |
| Cost of revenue | $2.2M | $3.4M | $3.1M | $2.6M | $2.5M | $2.5M | $2.3M | $2.2M | $2.1M | $2.1M | $2.0M | $1.9M |
| Gross profit | $25.9M | $23.1M | $21.6M | $19.9M | $18.7M | $18.0M | $16.2M | $15.0M | $12.8M | $12.8M | $11.1M | $9.7M |
| Research & development | $6.7M | $6.2M | $5.1M | $5.0M | $4.9M | $4.2M | $3.9M | $3.4M | $3.1M | $3.1M | $2.7M | $2.3M |
| Sales, general & admin | $39.2M | $37.7M | $31.2M | $29.6M | $28.8M | $28.0M | $25.2M | $21.6M | $18.1M | $18.1M | $16.8M | $14.6M |
| Total operating expenses | $45.9M | $43.9M | $36.2M | $34.6M | $33.6M | $32.2M | $29.1M | $24.9M | $21.2M | $21.2M | $19.5M | $16.9M |
| Operating income | −$20.0M | −$20.7M | −$14.6M | −$14.6M | −$15.0M | −$14.2M | −$12.9M | −$9.9M | −$8.4M | −$8.4M | −$8.4M | −$7.2M |
| Interest expense | $438,000 | $434,000 | $462,000 | $480,000 | $477,000 | $471,000 | $499,000 | $530,000 | $481,500 | $481,500 | $513,000 | $532,000 |
| Income before taxes | −$19.3M | −$19.7M | −$13.5M | −$13.5M | −$13.6M | −$12.8M | −$12.6M | −$10.4M | −$8.7M | −$8.7M | −$8.3M | −$7.1M |
| Net income | −$19.3M | −$19.7M | −$13.5M | −$13.5M | −$13.6M | −$12.8M | −$12.6M | −$10.4M | −$8.7M | −$8.7M | −$8.3M | −$7.1M |
| EBITDA | −$18.6M | −$19.1M | −$12.8M | −$12.6M | −$12.8M | −$12.0M | −$11.7M | −$9.6M | −$8.0M | −$8.0M | −$6.1M | −$6.3M |
| EPS (diluted) | −$0.51 | −$0.38 | −$0.36 | −$0.37 | −$0.38 | −$0.36 | −$0.40 | −$1.85 | −$0.37 | — | — | — |
| Gross margin | 92.3% | 87.3% | 87.3% | 88.3% | 88.1% | 87.9% | 87.6% | 87.3% | 85.8% | 85.8% | 84.7% | 83.8% |
| Operating margin | −71.1% | −78.3% | −58.9% | −64.8% | −70.5% | −69.3% | −69.5% | −57.8% | −56.8% | −56.8% | −63.8% | −61.7% |
| Net margin | −68.6% | −74.5% | −54.6% | −59.6% | −64.4% | −62.4% | −67.9% | −60.6% | −58.8% | −58.8% | −63.0% | −60.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CBLL's financial statements (latest annual report filed February 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.
CBLL financial results
In fiscal year 2025 (ended December 31, 2025), CeriBell reported revenue of $89.1 million, up 36.1% from the year before. It had a net loss of $53.4 million, a net profit margin of −60.0%. Diluted earnings per share came to −$1.47.
See the CBLL stock overview for the latest quote and news, or the CBLL chart for price history and technical indicators.
CBLL income statement FAQ
What is CeriBell's annual revenue?
CeriBell reported total revenue of $89.1 million for fiscal year 2025, which ended on December 31, 2025. That was up 36.1% from $65.4 million the previous year.
Is CeriBell profitable?
No. CeriBell reported a net loss of $53.4 million in fiscal 2025, a net profit margin of −60.0%; its operating margin was −65.6%.
What is CeriBell's gross margin?
CeriBell's gross margin was 87.9% in fiscal 2025: for every $100 of revenue, CeriBell kept $88 after the direct cost of its products and services.
How much does CeriBell spend on research and development?
CeriBell spent $19.1 million on research and development in fiscal 2025, 21.5% of revenue.
What are CeriBell's earnings per share?
CeriBell earned $-1.47 per diluted share in fiscal 2025, compared with $-2.62 a year earlier.
When will CeriBell report its next earnings?
CeriBell is expected to report results for the quarter ending September 30, 2026 on November 3, 2026 after the market closes.
When does CeriBell's fiscal year end?
CeriBell's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on February 24, 2026.